Furthermore, given their prevalence in APS-1, RAG1/RAG2-associated immunodeficiencies, SLE, and now IPEX, it will be important to consider type I IFN ACAAs as potential diagnostics and biomarkers both in immunodeficiency and autoimmunity. Here, RAG2 is linked to immunodeficiency disease.